TSE:MFC

Manulife Financial (MFC.TO)

57.19
+0.15 (0.26%)
as of Jun 26, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
BUY

Likes it. Just raised the dividend. Next increase late 2015. They are beneficiaries of high rates, but have the best growth in Asia (30-35%). Prefers this to any others. Standard Life acquisition was good even if they paid a lot.

DON'T BUY

Would prefer SLF-T. This one was over leveraged at the wrong time toward stocks in 2007/8. They are now deleveraging themselves against interest rates at the wrong time.

BUY

Finds the banks very boring. They just came out with earnings. Would prefer an insurer to the banks and thinks MFC-T purchase of Standard Life does a lot for them. It is a fantastic purchase.

TOP PICK

(A Top Pick Oct 22/13. Up 22.8%.) This pick has quite a bit to do with the expectation of higher interest rates. They are making money now and firing on all cylinders. This is a company where if you get a normalized yield curve, it doesn’t hurt them, but actually helps them. It should continue to do very well. Has a big Asian operation, which could do very, very well. Yield of 2.85%.

BUY

Just recently bought it. Sees rates going higher. He also sees a higher stock market. The core business has growth potential. The stock is not expensive. The life companies have lagged the banks. He would own both over the long term.

BUY

Manulife (MFC-T) or Sun Life (SLF-T)? These are equal as to which one he likes. This one has a model price of $25.72, a 16% upside. You have got to love the insurance companies. 2.5 years ago they were both coming out of the blue (his strategy). He has been holding both and they are both great. Thinks they will do well.

BUY

Receipts are being offered because of the Standard Life acquisition. If the deal falls through, you will get your money back. She would buy the receipts, and upon the deal closing, you turn it into the stocks. She likes lifecos in this environment. Rate increases tend to be very good for them.

BUY

With its most recent move to buy Standard Life’s Canadian business, it raised its dividend for the first time since it halved it in 2009. Very encouraging sign. Still likely to have further dividend increases.

TOP PICK

He added some on in that equity deal last week. The valuations on life companies are a little better than banks right now. Standard Life acquisition: he thinks they are underplaying the earnings accretion. They’ve really turned the corner.

COMMENT

Seasonal strength tends to run from about March through until June and is positive about 80% of the time. Through the end of the year, it can be variable. If you see some weakness here, that would be an opportunity to Buy. Chart is showing a bit of consolidation at around $22.50. If it breaks out above $22.50, that would be a Buy. He expects there will be a bit of consolidation lower than it is here. The peak period of seasonal strength is from March through to June.

TOP PICK

Thinks that inevitably higher rates are coming in. This is a nice combination. Just raised the dividend. Good earnings growth. Also, if rates go up faster than you think, this will be one of the beneficiaries. The Standard Life acquisition is accretive. Yield of 2.70%. Looking for $25 a year from now.

BUY

The insurance side is struggling in Canada, but they think there is growth in Asia. This is the benefit of the standard life acquisition.

BUY

MFC-T versus the banks? He looks for sectors that have gone through some material change that could support out-performance going forward. This is in a sector that under-performed for a long time while equity markets were weak. 2012 marked the beginning of a new secular bull market for stocks so you invest in companies that make money from that. This company is in the wealth management business. It looks like they will have greater growth in earnings going forward, yet it trades at a multiple that is cheaper than the banks. Expects the dividend growth will accelerate yearly and earnings will continue to get better.

TOP PICK

Started getting interested when it looked like the earnings were becoming less volatile and management was able to focus on their core earnings. She wanted to see BV growth, which would translate to a higher ROE. The stock price has lagged the Canadian banks and Sun Life (SLF-T). Likes their exposure to Asia, which is 30% of their earnings. Thinks this is a higher growth region in this market. Increased their dividend by 19% last quarter, which sent a strong signal that management was very comfortable with the sustainability of their earnings going forward. Liked the acquisition of Standard Life. Yield of 2.82%.

DON'T BUY

Got out during the financial crisis because they were overleveraged. Now he feels they are underleveraged. Prefers SLF-T. Owns PWF-T also. The deal with MFC-T yesterday underlines his feelings.

Showing 976 to 990 of 2,281 entries